Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 850 participants.

Also called NCT06526195

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 850 participants (planned count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06526195
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Austria, Czechia, Denmark, Germany, Italy, Netherlands, Saudi Arabia (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06526195. Randomized; no masking; primary purpose treatment. Start 2024-12-13 (actual); primary completion 2029-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Acronym
TEAM-HF
Condition
Heart Failure
Condition
Heart Diseases
Condition
Cardiovascular Diseases
Intervention (Device)
CardioMEMS HF System
Intervention (Device)
HeartMate 3 Left Ventricular Assist System
Intervention (Other)
Guideline Medical Directed Therapy
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct06526195
Content hash
caa8197e43c4afc35d84259f544f4656550c113a32066ae247ff7c3f0952e240